Norges Bank Crispr Therapeutics Ag Transaction History

Norges Bank

$655 Billion
Q2 2024

A detailed history of Norges Bank transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Norges Bank holds 650,208 shares of CRSP stock, worth $33.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

650,208

Holding current value

$33.7 Million

% of portfolio

0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$51.17 - $68.18 $33.3 Million - $44.3 Million	650,208 New	650,208 $35.1 Million
Q4 2023 Feb 09, 2024	BUY	$38.62 - $72.18 $23.9 Million - $44.6 Million	617,586 New	617,586 $38.7 Million
Q3 2023 Nov 13, 2023	SELL	$45.39 - $59.0 $30.3 Million - $39.3 Million	-666,768 Closed	0 $0
Q2 2023 Aug 14, 2024	SELL	$43.47 - $67.77 $3.18 Million - $4.96 Million	-73,175 Reduced 11.25%	577,033 $32.4 Million
Q2 2023 Aug 14, 2023	SELL	$43.47 - $67.77 $25.7 Million - $40 Million	-590,577 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$41.0 - $56.12 $25.8 Million - $35.3 Million	629,652 New	629,652 $28.5 Million
Q4 2022 Feb 14, 2023	BUY	$39.19 - $65.67 $28 Million - $47 Million	715,428 New	715,428 $29.1 Million
Q3 2022 Nov 13, 2023	BUY	$61.1 - $83.78 $40.7 Million - $55.9 Million	666,768 New	666,768 $43.6 Million
Q2 2022 Aug 14, 2023	BUY	$43.23 - $73.83 $25.5 Million - $43.6 Million	590,577 New	590,577 $35.9 Million
Q1 2022 May 12, 2023	SELL	$53.19 - $79.24 $5.4 Million - $8.05 Million	-101,595 Reduced 14.2%	613,833 $38.5 Million
Q1 2022 May 09, 2022	SELL	$53.19 - $79.24 $31.5 Million - $47 Million	-592,737 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$70.09 - $111.29 $41.5 Million - $66 Million	592,737 New	592,737 $44.9 Million
Q3 2021 Nov 14, 2022	BUY	$110.2 - $156.64 $73.3 Million - $104 Million	665,607 New	665,607 $74.5 Million
Q3 2021 Nov 05, 2021	SELL	$110.2 - $156.64 $68.8 Million - $97.8 Million	-624,090 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$100.84 - $161.89 $62.9 Million - $101 Million	624,090 New	624,090 $101 Million
Q2 2021 Aug 10, 2021	SELL	$100.84 - $161.89 $56.1 Million - $90.1 Million	-556,261 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$110.72 - $210.04 $61.6 Million - $117 Million	556,261 New	556,261 $67.8 Million
Q1 2021 May 07, 2021	SELL	$110.72 - $210.04 $62.3 Million - $118 Million	-563,091 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$79.67 - $173.23 $44.9 Million - $97.5 Million	563,091 New	563,091 $86.2 Million
Q4 2020 Feb 10, 2021	SELL	$79.67 - $173.23 $45.6 Million - $99.2 Million	-572,387 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$78.5 - $100.64 $44.9 Million - $57.6 Million	572,387 New	572,387 $47.9 Million
Q3 2020 Nov 10, 2020	SELL	$78.5 - $100.64 $39.1 Million - $50.2 Million	-498,478 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$38.5 - $76.05 $19.2 Million - $37.9 Million	498,478 New	498,478 $36.6 Million
Q2 2020 Aug 07, 2020	SELL	$38.5 - $76.05 $6.26 Million - $12.4 Million	-162,717 Closed	0 $0
Q1 2020 May 07, 2021	BUY	$33.68 - $62.53 $5.48 Million - $10.2 Million	162,717 New	162,717 $6.9 Million
Q1 2020 May 08, 2020	SELL	$33.68 - $62.53 $678,988 - $1.26 Million	-20,160 Closed	0 $0
Q4 2019 Mar 03, 2020	BUY	$36.68 - $73.13 $739,468 - $1.47 Million	20,160 New	20,160 $1.23 Million
Q4 2019 Feb 12, 2020	SELL	$36.68 - $73.13 $739,468 - $1.47 Million	-20,160 Closed	0 $0
Q3 2019 Nov 13, 2020	BUY	$40.99 - $52.56 $826,358 - $1.06 Million	20,160 New	20,160 $826,000

Others Institutions Holding CRSP

# of Institutions

499

Shares Held

56.8M

Call Options Held

1.7M

Put Options Held

1.8M

Capital International Investors Los Angeles, CA

7.87M
Shares

$408 Million
0.09% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

7.5M
Shares

$389 Million
3.35% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

2.97M
Shares

$154 Million
0.1% of portfolio
Nikko Asset Management Americas, Inc.

2.97M
Shares

$154 Million
1.61% of portfolio
Black Rock Inc. New York, NY

2.78M
Shares

$144 Million
0.0% of portfolio

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.05B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account